Protoscolicidal effects of curcumin nanoemulsion against protoscoleces of Echinococcus granulosus

BMC Complementary Medicine and Therapies - Tập 23 - Trang 1-9 - 2023
Aref Teimouri1, Sanaz Jafarpour Azami2, Saeedeh Hashemi Hafshejani2, Mohammad Ghanimatdan1, Mohammad Saleh Bahreini1, Rasoul Alimi3, Seyed Mahmoud Sadjjadi1
1Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3Department of Epidemiology and Biostatistics, School of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran

Tóm tắt

The aim of the present study was to assess in vitro protoscolicidal effects of curcumin nanoemulsion (CUR-NE) against protoscoleces of cystic echinococcosis (CE)/hydatid cysts. The CUR-NE was prepared via spontaneous emulsification of soybean as the oil phase, a mixture of Tween 80 and Tween 85 as the surfactant, ethanol as the co-surfactant and distilled water. Various concentrations of CUR-NE (156, 312, 625 and 1250 µg/ml) were exposed to collected protoscoleces of infected sheep liver hydatid cysts for 10, 20, 30, 60 and 120 min. Viability of the protoscoleces were assessed using eosin exclusion test. Morphological changes of the protoscoleces were observed using differential interference contrast (DIC) microscopy. The mean particle size and zeta potential of CUR-NE included 60.4 ± 14.8 nm and − 16.1 ± 1.1 mV, respectively. Results showed that the viability of the protoscoleces decreased significantly with increases in CUR-NE concentrations (p < 0.001). The mortality rates of protoscoleces with exposure to concentrations of 1250 and 625 µg/ml of CUR-NE for 60 min were 94 and 73.33%, respectively. Mortality of the protoscoleces was 100% after 120 min of exposure to 1250 and 625 µg/ml concentrations of CUR-NE. Using NIC microscopy, extensively altered tegumental surface protoscoleces was observed after protoscoleces exposure to CUR-NE. The findings of the present study revealed the in vitro protoscolicidal potential of CUR-NE. Therefore, CUR-NEs are addressed as novel protoscolicidal agents, which can be used as an alternative natural medicine to kill the protoscoleces, owing to their low toxicity and significant inhibition potency. However, further studies are necessary to investigate pharmacologic and pharmacokinetics of CUR-NEs.

Tài liệu tham khảo

WHO (World Health Organization). First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Geneva: WHO; 2010.

Higuita N, Iván A, Brunetti E, McCloskey C. Cystic echinococcosis. J Clin Microbiol. 2016;54:518–23. https://doi.org/10.1128/JCM.02420-15.

Thompson RCA. Biology and systematics of Echinococcus. Adv Parasitol. 2017;95:65–109. https://doi.org/10.1016/bs.apar.2016.07.00.

Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP. Echinococcosis: advances in the 21st century. Clin Microbiol Rev. 2019;32:e00075–18. https://doi.org/10.1128/CMR.00075-18.

Torgerson PR, Robertson LJ, Enemark HL, Foehr J, van der Giessen JWB, Kapel CMO, Klun I, Trevisan C. Source attribution of human echinococcosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2020;14:e0008382. https://doi.org/10.1371/journal.pntd.0008382.

Horton R. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop. 1997;64:79–93.

Zhuangzhuang J, Bohan C, Yingliang W, Yue Y, He Z, Jiabao L, Longhuan P, Lunhao B. Curcumin exerts chondroprotective effects against osteoarthritis by promoting AMPK/PINK1/Parkin-mediated mitophagy. Biomed Pharmacother. 2022;151:113092. https://doi.org/10.1016/j.biopha.2022.113092.

Azami SJ, Teimouri A, Keshavarz H, Amani A, Esmaeili F, Hasanpour H, Elikaee S, Salehiniya H, Shojaee S. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. Int J Nanomed. 2018;13:7363–74. https://doi.org/10.2147/IJN.S181896.

Napooni S, Delavari M, Arbabi M, Barkheh H, Rasti S, Hooshyar H, Hosseinpour Mashkani M, S. Scolicidal Effects of Chitosan-Curcumin Nanoparticles on the Hydatid Cyst Protoscolices. Acta Parasitol. 2019;64(2):367–75. https://doi.org/10.2478/s11686-019-00054-8.

Firouzeh N, Eslaminejad T, Shafiei R, Faridi A, Fasihi Harandi M. Lethal in vitro effects of optimized chitosan nanoparticles against protoscoleces of Echinococcus granulosus. J Bioactive Compatible Polym. 2021;36(3):237–48. https://doi.org/10.1177/08839115211014219.

Sharifi S, Fathi N, Memar MY, Hosseiniyan Khatibi SM, Khalilov R, Negahdari R, Vahed Z, Maleki S, Dizaj S. Anti-microbial activity of curcumin nanoformulations: new trends and future perspectives. Phytother Res. 2020;34(8):1926–46. https://doi.org/10.1002/ptr.6658.

Kohansal MH, Nourian A, Rahimi MT, Daryani A, Spotin A, Ahmadpour E. Natural products applied against hydatid cyst protoscolices: a review of past to present. Acta Trop. 2017;176:385–94. https://doi.org/10.1016/j.actatropica.2017.09.013.

Mahmoudvand H, Pakravanan M, Aflatoonian MR, Khalaf AK, Niazi M, Mirbadie SR, Tavakoli Kareshk A, Khatami M. Efficacy and safety of Curcuma longa essential oil to inactivate hydatid cyst protoscoleces. BMC Complement Altern Med. 2019;19(1):187. https://doi.org/10.1186/s12906-019-2527-3.

Sadjjadi SM, Zoharizadeh MR, Panjeshahin MR. In vitro screening of different Allium sativum extracts on hydatid cysts protoscoleces. J Invest Surg. 2008;21(6):318–22. https://doi.org/10.1080/08941930802348261.

Hosseini SV, Ghanbarzadeh K, Barzin J, Sadjjadi SM, Tanideh N, Mehrabani D. (2006). In vitro protoscolicidal effects of hypertonic glucose on protoscolices of hydatid cyst. Korean J Parasitol. 44(3) (2006) 239–242. https://doi.org/10.3347/kjp.2006.44.3.239

Tabatabaei ZS, Dehshahri S, Taghi MM, Esfandiari F, Sadjjadi FS, Ebrahimipour M, Sadjjadi SM. In Vitro Study on Protoscolicidal Effect of Methanolic Extract of Allium hirtifolium on Protoscoleces of cystic echinococcosis. Infect Disord – Drug Targets. 2019;19(3):264–8. https://doi.org/10.2174/1871526518666180509130838.

Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials. 3rd ed. Baltimore: Williams and Wilkins; 1996.

Teimouri A, Azami SJ, Keshavarz H, Esmaeili F, Alimi R, Mavi SA, Shojaee S. Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomedicine. 2018;8(13):1341–51. https://doi.org/10.2147/IJN.S158736. PMID: 29563791; PMCID: PMC5849388.

Oppenheimer A. Turmeric (curcumin) in biliary diseases. Lancet. 1937;229(5924):619–21.

Vogel A, Pelletier J. Examen chimique de la racine de Curcuma. [Chemical review of tuemric root]. J Pharm. 1815;1:289–300. French.

Ali BH, Marrif H, Noureldayem SA, Bakheit AO, Blunden G. Some Biological Properties of Curcumin: a review. Nat Prod Commun. 2006. https://doi.org/10.1177/1934578X0600100613.

Albalawi AE, Alanazi AD, Baharvand P, Sepahvand M, Mahmoudvand H. High potency of Organic and Inorganic Nanoparticles to treat cystic echinococcosis: an evidence-based review. Nanomaterials. 2020;10(12):2538. https://doi.org/10.3390/nano10122538.

Hamad SM, Shnawa BH, Jalil PJ, Ahmed MH. Assessment of the therapeutic efficacy of silver nanoparticles against secondary cystic echinococcosis in BALB/c mice. Surfaces. 2022;5:91–112. https://doi.org/10.3390/surfaces5010004.

Kumar A, Dhamgaye S, Maurya IK, Singh A, Sharma M, Prasad R. Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans. Antimicrob Agents Chemother. 2014;58(1):167–75. https://doi.org/10.1128/AAC.01385-13.